MLchartDataset catalogue

autologous anti-CD83 CAR T cells

Term · Oncology and biomedicine · MLC-T-ONC-011410

A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD83, with potential antineoplastic activity. Upon administration, autologous anti-CD83 CAR T cells recognize and kill CD83-expressing tumor cells. CD83 is expressed on acute myeloid leukemia (AML) blasts.

Table 1. Record
IdentifierMLC-T-ONC-011410
FieldOncology and biomedicine
Synonymsautologous anti-CD83 CAR-T cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011410",
  "term": "autologous anti-CD83 CAR T cells",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD83, with potential antineoplastic activity. Upon administration, autologous anti-CD83 CAR T cells recognize and kill CD83-expressing tumor cells. CD83 is expressed on acute myeloid leukemia (AML) blasts.",
  "synonyms": [
    "autologous anti-CD83 CAR-T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-anti-cd83-car-t-cells/"
}

Record 2,742 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.